151 related articles for article (PubMed ID: 10331000)
1. Immunization with Escherichia coli-produced soluble MHC class I proteins induces accelerated rejection or prolonged survival of rat cardiac allografts.
Perez J; Yu J; Stepkowski SM; Kahan BD
Transplant Proc; 1999 May; 31(3):1560. PubMed ID: 10331000
[No Abstract] [Full Text] [Related]
2. Allograft survival following immunization with membrane-bound or soluble peptide MHC class I donor antigens: factors relevant for the induction of rejection by indirect recognition.
Terness P; Dufter C; Otto G; Opelz G
Transpl Int; 1996; 9(1):2-8. PubMed ID: 8748404
[TBL] [Abstract][Full Text] [Related]
3. Allopeptide-mediated expression of endothelial Fas-ligand (CD95L) in long-term tolerized heterotopic rat heart grafts.
Fändrich F; Dresske B; Lin X; Huang DS; Zavazava N; Henne-Bruns D
Transplant Proc; 1999 May; 31(3):1558-9. PubMed ID: 10330999
[No Abstract] [Full Text] [Related]
4. Localization of immunogenic and tolerogenic epitopes in the RT1.A1 alloantigen.
Wang M; Yu J; Stepkowski SM; Kahan BD
Transplant Proc; 1999 May; 31(3):1517-8. PubMed ID: 10330987
[No Abstract] [Full Text] [Related]
5. Induction of tolerance by oral administration of a tolerogenic allochimeric donor/recipient class I MHC protein.
Stepkowski SM; Yu J; Wang M; Kahan BD
Transplant Proc; 1999 May; 31(3):1557. PubMed ID: 10330998
[No Abstract] [Full Text] [Related]
6. Induction of donor-specific tolerance by chimeric class I MHC molecules bearing donor alpha 1 helical amino acids.
Wang M; Yu J; Wang ME; Tian L; Stepkowski SM; Kahan BD
Transplant Proc; 1997; 29(1-2):1224-5. PubMed ID: 9123284
[No Abstract] [Full Text] [Related]
7. Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules.
Ghobrial RR; Hamashima T; Wang ME; Wang M; Stepkowski SM; Kahan BD
Transplantation; 1996 Oct; 62(7):1002-10. PubMed ID: 8878396
[TBL] [Abstract][Full Text] [Related]
8. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.
Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T
Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544
[No Abstract] [Full Text] [Related]
9. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
[TBL] [Abstract][Full Text] [Related]
10. Induction of specific allograft immunity by soluble class I MHC heavy chain protein produced in a baculovirus expression system.
Wang M; Stepkowski SM; Wang ME; Tian L; Qu X; Tu Y; He G; Kahan BD
Transplantation; 1996 Feb; 61(3):448-57. PubMed ID: 8610360
[TBL] [Abstract][Full Text] [Related]
11. Heart allograft survival in rats following immunization with soluble peptide MHC class I donor antigens: evidence for the role of indirect recognition in rejection.
Terness P; Dufter C; Post S; Thies J; Otto G; Koru T; Opelz G
Transpl Int; 1994; 7 Suppl 1():S584-5. PubMed ID: 11271314
[TBL] [Abstract][Full Text] [Related]
12. Intrathymic injection of alloantigen may lead to hyperacute rejection and prolonged graft survival of heart allografts in the rat.
de Bruin RW; van Rossum TJ; Scheringa M; Bonthuis F; IJzermans JN; Marquet RL
Transplantation; 1995 Nov; 60(9):1061-3. PubMed ID: 7491686
[No Abstract] [Full Text] [Related]
13. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
[TBL] [Abstract][Full Text] [Related]
14. Soluble donor MHC class I gene therapy prevents accelerated heart allograft rejection in actively sensitized rat recipients.
Tange S; Graeb C; Scherer MN; Frank E; Jauch K; Geissler EK
Transplant Proc; 2001; 33(1-2):579-80. PubMed ID: 11266966
[No Abstract] [Full Text] [Related]
15. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
16. Intrathymic immunomodulation of sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
Stadlbauer TH; Onodera K; Schaub M; Korom S; Binder J; Sayegh MH; Kupiec-Weglinski JW
Transplant Proc; 1997; 29(1-2):1016. PubMed ID: 9123176
[No Abstract] [Full Text] [Related]
17. Induction of antigen-specific tolerance: antigen form and injection route.
Yoshimura N; Hamashima T; Oka T
Transplant Proc; 1996 Jun; 28(3):1150-1. PubMed ID: 8658604
[No Abstract] [Full Text] [Related]
18. Modulation of alloimmunity with class I MHC peptides: mechanisms of action.
Mhoyan A; Wu GD; Que X; Cramer DV; Shirwan H
Transplant Proc; 1999; 31(1-2):1189-91. PubMed ID: 10083530
[No Abstract] [Full Text] [Related]
19. Induction of transplantation tolerance to rat cardiac allografts by intrathymic inoculation of allogeneic soluble peptides.
Oluwole SF; Chowdhury NC; Jin MX; Hardy MA
Transplantation; 1993 Dec; 56(6):1523-7. PubMed ID: 8279028
[TBL] [Abstract][Full Text] [Related]
20. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
